Dose Dense Chemo Better for Hormone-Negative

Dose-dense chemotherapy—chemo every two weeks—yields better results than standard chemo for hormone-receptive negative breast cancer, according to a meta-analysis using The Cochrane Cancer Network register of trials, The Cochrane Library, and LILACS and MEDLINE databases from January 1966 to January 2010. Researchers, however, say the studies they analyzed were inconsistent and they recommend randomized control trials. Read the full article, in the December 15, 2010 Journal of the National Cancer Institute.